Intelicanna Ltd Logo

Intelicanna Ltd

INTL.TA

(0.0)
Stock Price

110,00 ILA

0% ROA

0% ROE

0x PER

Market Cap.

0,00 ILA

0% DER

0% Yield

0% NPM

Intelicanna Ltd Stock Analysis

Intelicanna Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Intelicanna Ltd Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Intelicanna Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Intelicanna Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Intelicanna Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Intelicanna Ltd Revenue
Year Revenue Growth
2012 2.683.791.226
2013 2.765.550.071 2.96%
2014 3.105.950.133 10.96%
2015 3.008.794.773 -3.23%
2016 3.278.434.018 8.22%
2017 3.539.075.640 7.36%
2018 3.508.350.918 -0.88%
2019 3.815.097.032 8.04%
2020 2.059.886.829 -85.21%
2021 3.276.946.233 37.14%
2022 4.066.463.029 19.42%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Intelicanna Ltd Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Intelicanna Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 318.186.447
2013 300.954.935 -5.73%
2014 310.656.961 3.12%
2015 255.787.727 -21.45%
2016 260.299.374 1.73%
2017 337.710.095 22.92%
2018 358.312.092 5.75%
2019 461.819.937 22.41%
2020 533.547.592 13.44%
2021 615.261.060 13.28%
2022 780.384.938 21.16%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Intelicanna Ltd EBITDA
Year EBITDA Growth
2012 44.084.998
2013 -145.868.026 130.22%
2014 -8.358.769 -1645.09%
2015 -56.284.205 85.15%
2016 -54.873.102 -2.57%
2017 -42.814.141 -28.17%
2018 -54.057.795 20.8%
2019 -41.328.887 -30.8%
2020 -6.692.032 -517.58%
2021 -51.446.798 86.99%
2022 -51.787.536 0.66%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Intelicanna Ltd Gross Profit
Year Gross Profit Growth
2012 2.683.791.226
2013 2.765.550.071 2.96%
2014 3.105.950.133 10.96%
2015 3.008.794.773 -3.23%
2016 3.278.434.018 8.22%
2017 3.539.075.640 7.36%
2018 3.508.350.918 -0.88%
2019 3.815.097.032 8.04%
2020 2.059.886.829 -85.21%
2021 3.276.946.233 37.14%
2022 4.066.463.029 19.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Intelicanna Ltd Net Profit
Year Net Profit Growth
2012 814.589.502
2013 550.181.330 -48.06%
2014 799.147.255 31.15%
2015 907.898.708 11.98%
2016 1.046.941.316 13.28%
2017 1.263.276.628 17.12%
2018 1.180.754.297 -6.99%
2019 1.287.328.041 8.28%
2020 95.986.164 -1241.16%
2021 898.504.073 89.32%
2022 1.217.377.686 26.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Intelicanna Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 10
2013 7 -66.67%
2014 10 40%
2015 11 9.09%
2016 13 15.38%
2017 16 13.33%
2018 15 -7.14%
2019 16 12.5%
2020 1 -1500%
2021 11 90.91%
2022 15 26.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Intelicanna Ltd Free Cashflow
Year Free Cashflow Growth
2012 -3.449.619.271
2013 -180.626.251 -1809.81%
2014 -2.977.498.325 93.93%
2015 -2.222.335.289 -33.98%
2016 150.103.664 1580.53%
2017 -1.054.566.223 114.23%
2018 -1.783.152.933 40.86%
2019 -198.731.777 -797.27%
2020 -3.671.471.500 94.59%
2021 345.760.120 1161.86%
2022 -336.690.839 202.69%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Intelicanna Ltd Operating Cashflow
Year Operating Cashflow Growth
2012 -3.282.094.007
2013 -180.626.251 -1717.06%
2014 -2.876.516.398 93.72%
2015 -2.178.757.486 -32.03%
2016 182.915.996 1291.12%
2017 -1.010.154.059 118.11%
2018 -1.729.371.369 41.59%
2019 -158.054.507 -994.16%
2020 -3.644.321.528 95.66%
2021 372.778.543 1077.61%
2022 -286.057.596 230.32%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Intelicanna Ltd Capital Expenditure
Year Capital Expenditure Growth
2012 167.525.264
2013 0 0%
2014 100.981.927 100%
2015 43.577.803 -131.73%
2016 32.812.332 -32.81%
2017 44.412.164 26.12%
2018 53.781.564 17.42%
2019 40.677.270 -32.22%
2020 27.149.972 -49.82%
2021 27.018.423 -0.49%
2022 50.633.243 46.64%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Intelicanna Ltd Equity
Year Equity Growth
2012 4.360.205.248
2013 4.414.558.296 1.23%
2014 4.894.921.350 9.81%
2015 4.911.206.692 0.33%
2016 5.992.407.208 18.04%
2017 6.870.547.390 12.78%
2018 7.192.079.430 4.47%
2019 8.072.408.171 10.91%
2020 7.040.854.179 -14.65%
2021 6.777.149.767 -3.89%
2022 7.772.271.006 12.8%
2023 8.451.528.619 8.04%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Intelicanna Ltd Assets
Year Assets Growth
2012 40.749.180.966
2013 40.806.230.325 0.14%
2014 45.125.291.831 9.57%
2015 45.648.918.666 1.15%
2016 46.599.708.671 2.04%
2017 52.631.146.343 11.46%
2018 52.537.996.737 -0.18%
2019 56.698.560.338 7.34%
2020 65.690.692.596 13.69%
2021 61.372.788.572 -7.04%
2022 62.208.631.295 1.34%
2023 63.162.836.856 1.51%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Intelicanna Ltd Liabilities
Year Liabilities Growth
2012 7.460.871.524
2013 36.391.672.028 79.5%
2014 40.230.370.479 9.54%
2015 40.737.711.973 1.25%
2016 40.607.301.461 -0.32%
2017 45.760.598.952 11.26%
2018 45.345.917.307 -0.91%
2019 48.626.152.166 6.75%
2020 58.649.838.416 17.09%
2021 54.595.638.804 -7.43%
2022 54.436.360.288 -0.29%
2023 54.711.308.237 0.5%

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Intelicanna Ltd Dividends
Year Dividends Growth
2002 56
2003 147 62.33%
2004 464 68.53%
2005 271 -71.85%
2006 251 -7.57%
2007 213 -18.4%

Intelicanna Ltd Profile

About Intelicanna Ltd

Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.

CEO
Mr. Ori Weiss
Employee
8
Address
5 Menachem Begin Aveune
Beit Dagan, 50200

Intelicanna Ltd Executives & BODs

Intelicanna Ltd Executives & BODs
# Name Age
1 Mr. Haim Weiss
Chief Operating Officer
70
2 Mr. Balfour Moore
Co-Founder & Director
70
3 Mr. Ori Weiss
Chief Executive Officer & Director
70
4 Ms. Ilanit Halperin CPA
Chief Financial Officer & Vice President of Fin.
70
5 Mr. Zeev Ahronson
Head of Procurement, Project Management & R&D at Tefen Israel and Partner of Tefen Israel
70
6 Mr. Elijah Weiss
Director of Facility Growth
70
7 Mr. Zbigniew Brzezinski
Managing Partner of Tefen Poland and Chief Executive Officer of Tefen Poland
70
8 Ms. Neta Rosenberg Lavi
Head of Services & Operational Excellence at Tefen Israel and Partner of Tefen Israel
70
9 Ms. Ilanit Halperin C.P.A.
Chief Financial Officer & Vice President of Fin.
70
10 Mr. Nachshol Cohen
Vice President of Technology
70
11 Dr. Philippe Salphati
MD & Partner of Tefen Swiss
70
12 Ms. Mally Bitzur-Parnes
Chief Executive Officer of Tefen Israel
70

Intelicanna Ltd Competitors

InterCure Ltd. Logo
InterCure Ltd.

INCR.TA

(2.2)
Galileo Tech Ltd Logo
Galileo Tech Ltd

GLTC.TA

(0.8)
Panaxia Labs Israel Ltd Logo
Panaxia Labs Israel Ltd

PNAX.TA

(1.5)
Together Pharma Ltd Logo
Together Pharma Ltd

TGTR.TA

(0.0)